Vladas Algirdas Bumelis, CEO of Northway Biotech, has been honored with the LRT Year Award for Business Leadership. This award recognizes his contributions to the biotechnology sector, particularly in advancing Lithuania’s position in life sciences. It highlights his role in the development of the BIO CITY biotechnology hub and the establishment of the Gene Therapy Centre in Vilnius.
The LRT Year Awards celebrate leadership across various fields, including politics, culture, science, and business. In the business category, Professor Bumelis was recognized for positioning Lithuania as a key player in biotechnology. The completion of the Gene Therapy Centre in just one year marks a major milestone for the country’s biotech industry.
BIO CITY, which will house 9 biopharmaceutical centers and attract substantial investment, is a key component of Professor Bumelis’s vision. The initiative aims to foster growth in the biotechnology sector, create jobs, and boost Lithuania’s economy. With continued investment and expansion, BIO CITY is set to become a leading center for innovation in biotechnology.
Congratulations to Professor Bumelis for this well-deserved recognition and his continued impact on the future of biotechnology in Lithuania.
Photo credit: Domantas Umbrasas and Justinas Stacevičius / LRT.
For further information, please contact:
Vladas Bumelis, CEO and Chairman of the Board vladas.bumelis@northwaybiotech.com